Why this list matters
Bring a complete list of everything you take, including over-the-counter medicines, vitamins and supplements, to your surgical and anesthesia teams. They decide what to continue, pause or adjust, and when. Nothing on this page is a reason to stop or change a medicine on your own.
A review of herbal medicines and surgery advises that physicians explicitly ask about and document herbal medicine use before surgery.Review4
The evidence in this section (1 source)
GLP-1 drugs (semaglutide, liraglutide, tirzepatide and others)
The Ozempic label reports rare cases of pulmonary aspiration in people taking GLP-1 receptor agonists. These people had food left in the stomach despite following fasting instructions before surgery or deep sedation.Official text1
One study used stomach ultrasound before anesthesia. In it, 56% of people taking a GLP-1 drug had increased stomach contents, against 19% of those not taking one.E2Good5
The authors suggested that standard fasting times may be inadequate for this group.E2Good5
A large cohort study of upper endoscopy found no increased aspiration risk with GLP-1 drugs compared with SGLT2 drugs. But more procedures had to be stopped, possibly because of food left in the stomach.E2Good6
A 2024 multisociety guidance says patients at low risk of delayed stomach emptying having elective surgery can continue GLP-1 drugs. It also says that people early in treatment, while the dose is being increased, are more likely to have delayed emptying.E2Good2
Some people are at the highest risk of significant stomach side effects. For them, the guidance describes a liquid diet for 24 hours before the procedure or other measures, depending on the circumstances.E2Good2
The Ozempic label, quoted as written:
There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations.
Sen's study enrolled 124 participants (median age 56 years; 60% female). Increased residual gastric content was found in 35 of 62 taking a GLP-1 receptor agonist and 12 of 62 not taking one.E2Good5
GLP-1 receptor agonist use was independently associated with increased residual gastric content on preprocedural gastric ultrasound.E2Good5
Alkabbani's comparative cohort study of upper endoscopy, quoted as written:
In this comparative cohort study, no increased risk of pulmonary aspiration during upper gastrointestinal endoscopy was observed among adults with type 2 diabetes using GLP-1 receptor agonists compared with SGLT-2 inhibitors within 30 days of the procedure; however, GLP-1 receptor agonists were associated with a higher risk of discontinuation of endoscopy, possibly owing to a higher risk of retained gastric content.
The evidence in this section (4 sources)
SGLT2 drugs (empagliflozin and others)
The Jardiance label gives this instruction to prescribers, quoted as written:
Withhold JARDIANCE for at least 3 days, if possible, prior to surgery or procedures associated with prolonged fasting. Resume JARDIANCE when the patient is clinically stable and has resumed oral intake [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.2)].
Your prescriber and surgical team decide whether and when this applies to you.
The evidence in this section (1 source)
| Source | Design | Grade | Citations (NIH iCite) |
|---|---|---|---|
| 7 Boehringer Ingelheim Pharmaceuticals, Inc., 2026 | FDA label | Official text | Not tracked |
Blood thinners and aspirin
A 2022 guideline from the American College of Chest Physicians made 44 recommendations on blood thinners around surgery. Two are strong: against heparin bridging in people with atrial fibrillation, and for continuing warfarin-type drugs during pacemaker or defibrillator implantation.E2Good3
The guideline has separate recommendations for minor procedures: dental, skin, eye, pacemaker and endoscopic procedures.E2Good3
In the BRIDGE trial, people with atrial fibrillation whose warfarin was paused for surgery did as well without bridging injections as with them for preventing clots. They also had less major bleeding (1.3% against 3.2%).E1Strong8
The PAUSE study used a standard plan for pausing direct oral anticoagulants, without bridging or blood tests. The plan was linked with low rates of major bleeding and stroke-type clots.E2Good9
In the POISE-2 trial, aspirin given before and after noncardiac surgery did not reduce death or heart attack but increased major bleeding.E1Strong10
For spinal, epidural and nerve block anesthesia, a regional anesthesia society notes that bleeding complications are extremely rare. It proposes conservative times for pausing blood thinners before these blocks.E2Good11
The 2022 CHEST guideline's summary, quoted as written:
A multidisciplinary panel generated 44 guideline recommendations for the perioperative management of VKAs, heparin bridging, DOACs, and antiplatelet drugs, of which two are strong recommendations: (1) against the use of heparin bridging in patients with atrial fibrillation; and (2) continuation of VKA therapy in patients having a pacemaker or internal cardiac defibrillator implantation.
In BRIDGE, a randomized trial, arterial thromboembolism occurred in 0.4% without bridging and 0.3% with bridging (risk difference 0.1 percentage points; 95% CI -0.6 to 0.8; P=0.01 for noninferiority).E1Strong8
Major bleeding occurred in 1.3% without bridging and 3.2% with bridging (relative risk 0.41; 95% CI 0.20 to 0.78; P=0.005 for superiority).E1Strong8
The ASRA guideline's approach to neuraxial and deep blocks, quoted as written:
It is impossible to perform large, randomized controlled trials evaluating a complication this rare; therefore, where the evidence is limited, the authors continue to maintain an 'antihemorrhagic' approach focused on patient safety and have proposed conservative times for the interruption of therapy prior to neural blockade.
The evidence in this section (5 sources)
| Source | Design | Grade | Citations (NIH iCite) |
|---|---|---|---|
| 3 Douketis JD, Chest, 2022 | Guideline | E2Good | 331 (RCR 35.35) |
| 8 Douketis JD, N Engl J Med, 2015 | Randomized trial | E1Strong | 817 (RCR 34.98) |
| 9 Douketis JD, JAMA Intern Med, 2019 | Observational study | E2Good | 409 (RCR 23.93) |
| 10 Devereaux PJ, N Engl J Med, 2014 | Randomized trial | E1Strong | 650 (RCR 25.12) |
| 11 Kopp SL, Reg Anesth Pain Med, 2025 | Guideline | E2Good | 77 (RCR 29.3) |
Herbal medicines and supplements
A review in JAMA describes bleeding from garlic, ginkgo and ginseng, and heart and blood pressure instability from ephedra. It describes low blood sugar from ginseng and stronger sedation from kava and valerian. It also describes faster breakdown of many surgical drugs caused by St John's wort.Review4
The JAMA review, quoted as written:
Direct effects include bleeding from garlic, ginkgo, and ginseng; cardiovascular instability from ephedra; and hypoglycemia from ginseng. Pharmacodynamic herb-drug interactions include potentiation of the sedative effect of anesthetics by kava and valerian. Pharmacokinetic herb-drug interactions include increased metabolism of many drugs used in the perioperative period by St John's wort.
The evidence in this section (1 source)
Smoking
Pooling six randomized trials, stopping smoking before surgery reduced complications by 41%. Each week of not smoking increased the effect by 19%, and stopping for at least 4 weeks had a larger effect.E1Strong12
Mills' meta-analysis pooled 6 randomized trials: relative risk reduction for postoperative complications 41% (95% CI 15 to 59, P = .01). Each week of cessation increased the effect by 19%, and trials of at least 4 weeks' cessation had a significantly larger effect than shorter trials (P = .04).E1Strong12
The authors concluded that longer periods of smoking cessation decrease the incidence of postoperative complications.E1Strong12
The evidence in this section (1 source)
Questions you might bring to your anesthesia team
- Here is my full list of medicines and supplements: which should I continue, pause or adjust, and when?
- I take a GLP-1 drug: does that change my fasting plan or my procedure day?
- I take an SGLT2 drug: what is the plan for it?
- I take a blood thinner or aspirin: who decides the plan, and do I need bridging?
- Is there anything to start before surgery, such as quitting smoking support?
